Protalix BioTherapeutics (PLX)
Add to Watchlists Create an Alert
5.21
+0.00 +0.00%
AMEX
May 23, 4:41PM
BATS Real time
Currency in USD
Protalix BioTherapeutics Revenue Quarterly:
0.494M for Dec. 31, 2012Protalix BioTherapeutics Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.494M |
| Sept. 30, 2012 | 5.39M |
| June 30, 2012 | 26.11M |
| March 31, 2012 | 3.728M |
| Dec. 31, 2011 | 6.107M |
| Sept. 30, 2011 | 0.897M |
| June 30, 2011 | 0.764M |
| March 31, 2011 | 6.00M |
| Dec. 31, 2010 | 1.176M |
| Sept. 30, 2010 | 3.184M |
| June 30, 2010 | 1.141M |
| March 31, 2010 | 0.847M |
| Dec. 31, 2009 | 0.388M |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | |
| Sept. 30, 2008 | |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
PLX Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Pfizer | 13.50B |
| Peregrine Pharmaceuticals | 7.039M |
| Shire | 1.162B |
PLX Revenue Quarterly Rankings
| Overall |
40th percentile 4772 of 8006 |
| Sector |
30th percentile 476 of 686 in Healthcare |
| Industry |
49th percentile 125 of 248 in Biotechnology |
PLX Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 26.11M | Jun 2012 |
| Average | 3.308M |